Moreover, BRAF inhibitor treatment is associated with a decrease in immunosuppressive cytokines such IL-6 & IL-8 and CTGF in melanoma cells [43, 44] and tumor patients [37, 45]. The gene discussed is BRAF; the disease is neoplasm.